Related Experiment Video
Updated: Feb 3, 2026
Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Capitalizing on Insights from Human Genetics to Identify Novel Therapeutic Targets for Coronary Artery Disease
Erica P Young1, Nathan O Stitziel1,2,3
1Cardiovascular Division, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110, USA;
Insights
Human genetics offers a promising avenue for understanding coronary artery disease (CAD) and developing new preventative therapies. Identifying genetic variants associated with CAD risk can reveal causal mechanisms for targeted drug development.
Area of Science:
- Cardiovascular Research
- Human Genetics
- Pharmacology
Background:
- Coronary artery disease (CAD) is a leading cause of death and illness.
- Current pharmacopeia for CAD prevention remains insufficient despite extensive research.
- Developing effective cardiovascular drugs faces challenges in identifying therapeutically actionable targets.
Purpose of the Study:
- To review the utility of human genetics in identifying therapeutic targets for CAD.
- To explore the limitations of using genetic variants for CAD drug development.
- To enhance understanding of CAD pathogenesis through genetic insights.
Main Methods:
- Review of existing literature on human genetics and CAD.
- Analysis of genetic variants associated with CAD risk.
- Evaluation of the potential for genetic targets in therapeutic strategies.
Main Results:
- Genetic variants provide a pathway to understanding CAD mechanisms.
- Human genetics can guide the identification of novel therapeutic targets.
- Translating genetic findings into effective CAD therapies presents challenges.
Conclusions:
- Human genetics is a valuable tool for uncovering CAD pathogenesis.
- Genetic insights can accelerate the development of targeted CAD treatments.
- Further research is needed to overcome limitations in genetic-based drug discovery for CAD.
Abstract:
Coronary artery disease (CAD) is a major cause of morbidity and mortality. Unfortunately, despite decades of research focused on disease pathogenesis, we still lack a sufficient pharmacopeia for preventing CAD. The failure of many novel cardiovascular drugs to improve clinical outcomes reflects the major substantial challenge of drug development: identifying causal mechanisms that can be therapeutically manipulated to lower disease risk. Identifying genetic variants that are associated with risk of CAD has emerged as a clear path toward improving our understanding of the underlying mechanisms that lead to disease and to the development of new therapies. Here, we review the potential utility and limitations of using human genetics to guide the identification of therapeutic targets for CAD.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:27Coronary Artery Disease V: Interprofessional Care
01:30Coronary Artery Disease III: Clinical Manifestations
01:26Coronary Artery Disease IV: Preventive Measures
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...